Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Mark Gazall

Surgery Columbus, OH Doctor of Osteopathy

NPI 1124068622 CMS profile 141251

6503 E Broad St Ste 200, Columbus, OH 43213

Open in the dashboard

General payments

$51,736

220 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Mark Gazall of Columbus, OH is reported in the CMS Open Payments database as having received $51,736 across 220 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $442 6
2024 General $151 2
2023 General $824 9
2022 General $41,103 36
2021 General $5,481 82
2020 General $1,784 47
2019 General $1,952 38

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mark Gazall
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Mark Gazall were reported at $442. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Mark Gazall Surgery median Middle half National median
2019 $1,952 $253 $82–$1,521 $163
2020 $1,784 $131 $40–$706 $114
2021 $5,481 $168 $50–$904 $132
2022 $41,103 $224 $76–$1,218 $149
2023 $824 $253 $82–$1,255 $160
2024 $151 $279 $90–$1,381 $164
2025 $442 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AngioDynamics, Inc. $43,576 14 payments
  2. Abbott Laboratories $2,139 62 payments
  3. Cardiovascular Systems Inc. $1,315 42 payments
  4. Endologix, Inc. $1,241 9 payments
  5. Veryan Medical Incorporated $751 2 payments
  6. Philips Electronics North America Corporation $676 17 payments
  7. Janssen Pharmaceuticals, Inc $437 30 payments
  8. Shockwave Medical, Inc $364 3 payments
  9. Tactile Systems Technology Inc $345 15 payments
  10. Cordis US Corp. $294 6 payments
  11. Other $597 20 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Long term medical supply or device loan $40,000 2 payments
  2. Food and Beverage $8,990 213 payments
  3. Education $2,746 5 payments
Products named General payments · program years 2019–2025
  1. Auryon Laser System 100-120 Vac Et $42,772 5 payments
  2. Ovation $1,140 8 payments
  3. Peripheral Orbital Atherectomy System $1,008 29 payments
  4. Absolute Pro vascular stent system Vascular $832 21 payments
  5. AURYON LASER SYSTEM 100-120 VAC Pad $805 9 payments
  6. BioMimics $751 2 payments
  7. XARELTO $437 30 payments
  8. Supera peripheral stent system $369 9 payments
  9. Diamondback Peripheral $307 13 payments
  10. Absolute Pro vascular stent system Vascular $300 12 payments
  11. Other $3,514 104 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

220 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record